Erratum to: Efficacy of Additional Canagliflozin Administration to Type 2 Diabetes Patients Receiving Insulin Therapy: Examination of Diurnal Glycemic Patterns Using Continuous Glucose Monitoring (CGM).

Matsumura, Mihoko; Nakatani, Yuki; Tanka, Seiichi; Aoki, Chie; Sagara, Masaaki; Yanagi, Kazunori; Suzuki, Kunihiro; Aso, Yoshimasa

Matsumura, Mihoko; Nakatani, Yuki; Tanka, Seiichi; Aoki, Chie; Sagara, Masaaki; Yanagi, Kazunori; Suzuki, Kunihiro; Aso, Yoshimasa.

Afiliación

Matsumura M; Department of Endocrinology and Metabolism, Dokkyo Medical University, Tochigi, Japan. m-mihoko@dokkyomed.ac.jp.
Nakatani Y; Department of Endocrinology and Metabolism, Dokkyo Medical University, Tochigi, Japan.
Tanka S; Department of Diabetes and Endocrinology, Nikko Medical Center, Dokkyo Medical University, Tochigi, Japan.
Aoki C; Department of Endocrinology and Metabolism, Dokkyo Medical University, Tochigi, Japan.
Sagara M; Department of Endocrinology and Metabolism, Dokkyo Medical University, Tochigi, Japan.
Yanagi K; Department of Endocrinology and Metabolism, Dokkyo Medical University, Tochigi, Japan.
Suzuki K; Department of Endocrinology and Metabolism, Dokkyo Medical University, Tochigi, Japan.
Aso Y; Department of Endocrinology and Metabolism, Dokkyo Medical University, Tochigi, Japan.

Diabetes Ther ; 8(6): 1437, 2017 12.

Article en En | MEDLINE | ID: mdl-29063509

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Diabetes Ther Año: 2017 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google